There are 1,381 papers on ubiquitin–proteasome system in aging research: 35 trials and 94 observational studies in people, 828 in animals, 191 in cells, 209 reviews. The newest story, Nov 16, 2026: “Reducing a brain-development protein shortened life in flies”.
The findings reach people, from one lab or study; independent labs found the same change in worms or flies and mice. 75 independent labs in 26 countries.
“Many of the significant genes were involved in the ubiquitin-mediated proteolysis pathway.”
Worms or flies and mice: replicated by independent labs. Cells and humans: a single group.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
Includes the processes named after it and trials of drugs aimed at it.
Caloric restriction showed no clear effect on ubiquitin–proteasome system in rats (younger rats).
“CR-induced reduction of content/ phosphorylation levels of key proteins in mTOR signaling and the UPP occurred in the middle-aged rats but not younger rats.”
Caloric restriction decreases ubiquitin–proteasome system in rats (middle-aged rats).
“Unlike younger rats, CR decreased the content of phosphorylated mTOR, S6K, phosphorylated S6K, FOXO3a, and ubiquitinated proteins in middle-aged rats.”
Caloric restriction increases ubiquitin–proteasome system in rats.
“the activity of proteasome, which is suggested to be responsible for degradation of altered proteins, was found increased in the liver of rats 30 months of age subjected to 3.5 months of DR.”
Caloric restriction decreases ubiquitin–proteasome system in mice (non-stressed).
“steady-state levels of endogenous ubiquitin conjugates, de novo conjugate formation, and E1 and E2 activities were significantly lower in R animals than in control (C) animals.”
Strength training showed no clear effect on ubiquitin–proteasome system in humans (chronic, 10-week training, basal levels, ST + PRO group).
“The ten-week training intervention did not affect basal levels of autophagy mRNAs and proteins, and neither markers of the ubiquitin-proteasome system.”
Human trialchronic, 10-week training, basal levels, ST + PRO groupskeletal muscle10 weeks
Strength training activates ubiquitin–proteasome system in humans (acute, after the first session (untrained state), ST + PRO group).
“the acute training-induced activation of proteasomal degradation and autophagy seems to depend on training status, with activation in the untrained, but not trained state”
Human trialacute, after the first session (untrained state), ST + PRO groupskeletal muscleacute
Resistance training + protein intake increases ubiquitin–proteasome system in humans (Both ICU survivors and matched controls; effects reported for parts of the pathway).
“In both groups, the intervention increased anabolic signalling, decreased initiation of autophagy and increased parts of the ubiquitin-proteasome pathway.”
Human trialBoth ICU survivors and matched controls; effects reported for parts of the pathwayskeletal muscle24 g hydrolyzed protein
Thiolutin activates ubiquitin–proteasome system in yeast cells.
“In parallel, thiolutin triggers a selective adaptive response with activation of RPN4-mediated proteasome remodeling and redox-responsive genes, without HOG1 induction.”
Ubiquitin–proteasome system mediates stem cell fate decisions.
“We discuss how these post-translational events govern stem cell identity across haematopoietic, muscle, neural, mesenchymal, and pluripotent compartments.”
Ubiquitin–proteasome system increases bone loss in PMOP.
“Abnormal activity of these ubiquitin-associated enzymes often leads to excessive degradation or abnormal accumulation of key regulatory proteins in bone metabolism, thereby exacerbating bone loss in PMOP.”
Ubiquitin–proteasome system mediates tenovin-1-induced CLDN4 protein decrease in human cells (tested with proteasome inhibitors in Ten-1-treated cells).
“The Ten-1-induced decrease in CLDN4 protein was inhibited by clathrin-dependent endocytosis and proteasome inhibitors.”
Cellstested with proteasome inhibitors in Ten-1-treated cells
Oxidative stress and ROS signaling activates ubiquitin–proteasome system.
“oxidative stress and inflammation, which then activate signal transduction, such as the ubiquitin proteasome system, autophagy lysosome system, and mTOR”
Oxidative stress and ROS signaling activates ubiquitin–proteasome system in Sod1-/- mice.
“an increase in oxidative stress-induced muscle atrophy was also strongly coupled with simultaneous activation of two major proteolytic systems, the ubiquitin-proteasome and lysosomal autophagy pathways”
Age decreases ubiquitin–proteasome system in silico (BM-HSCs compared between aged and young donors).
“The down-regulation of signaling pathways such as longevity regulation, proteasome, Notch, apoptosis, nuclear factor kappa B (NFkB), and peroxisome proliferator-activated receptors (PPAR) signaling pathways”
In silicoBM-HSCs compared between aged and young donorsbone marrow hematopoietic stem cellsn = 10
“nuclear factor-erythroid 2-like bZIP factor 1 (NFE2L1, also known as Nrf1, with its long isoform TCF11 and short isoform LCR-F1) has been identified as an indispensable regulator of the transcriptional expression of the ubiquitin-proteasome system.”
“Nuclear factor erythroid 2- like 1 (NFE2L1) is a transcription factor primarily responsible for the proteasome inhibitor-induced "bounce-back effect" regulating the expression of proteasome subunits.”
BLM10 inhibits ubiquitin–proteasome system in yeast cells (overexpression of Blm10).
“Due to this competition for the CP, overexpression of Blm10 can lead to attenuation of ubiquitin-dependent degradation and consequent proteostatic defects.”
Ubiquitin–proteasome system is associated with lifespan in flies.
“driving RNAi toward proteasome components and regulators, using the GAL4-elav.L driver, resulted in changes to longevity and climbing-activity patterns during aging”
Model organismsshown by RNAi knockdown of proteasome components and regulators driven by elav.L-GAL4 in neuronsbrain
Normal-appearing white matter is associated with ubiquitin–proteasome system in NAWM versus control white matter (Enrichment score 5.14, p < 0.001).
“with significant dysregulation of protein de-ubiquitination (Enrichment score 5.14, p < 0.001), implying an inability to maintain protein homeostasis in NAWM”
Humansin NAWM versus control white mattermicroglia
Ubiquitin–proteasome system is associated with neurodegenerative disease in cancer and neurodegenerative disorders.
“Their dysregulation is emerging as a common thread linking these seemingly disparate diseases, necessitating a comprehensive understanding of their molecular intricacies.”
Alzheimer's disease is associated with ubiquitin–proteasome system in humans.
“Transcriptomic profiling suggested the dysregulation of proteolytic machinery involved in regulating platelet function, particularly the ubiquitin-proteasome system in AD”
Experiments reducing Ankle2 in adult fly nerve cells also impaired movement and accelerated nerve-cell loss, suggesting a role in maintaining neurons as they age.Experiments reducing Ankle2 in adult fly nerve cells also impaired movement and accelerated nerve-cell loss, suggesting a role in maintaining neurons as they age.
Older male mice, six per group, received nitrate or standard drinking water for three months; nitrate reduced signs of degeneration in a chewing muscle.Older male mice, six per group, received nitrate or standard drinking water for three months; nitrate reduced signs of degeneration in a chewing muscle.
In cell experiments, kidney-risk protein variants entered an internal membrane more readily than the comparison variant, while rapamycin reduced protein levels and cell…In cell experiments, kidney-risk protein variants entered an internal membrane more readily than the comparison variant, while rapamycin reduced protein levels and cell harm.
Worm experiments showed that increasing the enzyme preserved health during aging and strengthened stress responses.Worm experiments showed that increasing the enzyme preserved health during aging and strengthened stress responses.
In experiments in newborn mice, reducing SMURF2, an enzyme that tags proteins for breakdown, improved heart function and reduced scarring after heart injury.In experiments in newborn mice, reducing SMURF2, an enzyme that tags proteins for breakdown, improved heart function and reduced scarring after heart injury.